The Patent Finder

Terms ending in 2037

Universitat Basel

Every in-force patent on Universitat Basel's record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,484,572Use of HLA-B27 Homodimers for Cancer Treatment
In force
 · High confidence
Universitat ZurichIn forceHigh confidence
US 11,369,660Method of Treating Cancer with an HLA-B57 Open Conformer
In force
 · High confidence
Universitat BaselIn forceHigh confidence
US 12,144,299Mobilisation of Transposable Elements to Enhance Genetic and Epigenetic Variability in a Population
In force
 · High confidence
Universitat BaselIn forceHigh confidence
US 11,807,676MHC Class Ia Open Conformers
In force
 · High confidence
Universität BaselIn forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
2 of these are in force and held by Universitat Basel.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited